RHEOS MEDICAL CORP. — SEC Form D Filing

RHEOS MEDICAL CORP. filed an SEC Form D on October 7, 2026, reporting $233K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
October 7, 2026
Amount reported
$233K
Round stage
Pre-Seed
Industry
Medical Devices
Website
https://rheosmedical.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: NEVADA

Problem

Many patients on mechanical ventilation experience delirium due to current sedation practices, leading to significant costs and adverse health outcomes. Additionally, there's a market gap where existing medical devices have seen little innovation or have been overlooked.

Solution

Rheos Medical develops medical devices, such as Clarity-IA®, a next-generation anesthesia system that converts existing ventilators into anesthesia machines to precisely deliver inhaled sedatives and anesthetics, aiming to reduce the risk of delirium.

Why now

There's a growing recognition of the negative long-term impacts and high costs associated with delirium in ICU patients, coupled with a desire for more precise and cost-effective sedation methods in critical care.

Verdict

Investors said yes due to the immediate, tangible problem of ICU delirium and the promise of a novel device addressing it directly, not because of a proven market entry strategy or broad platform play. They were implicitly betting on a clear clinical pathway to adoption and the ability to navigate regulatory hurdles for a device that offers a demonstrable improvement over existing protocols. Upside was limited by the need for extensive clinical validation and the inherent sales cycles within hospital systems, suggesting a slow initial revenue ramp rather than rapid market penetration.

Source: SEC EDGAR Form D filing